UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$950M |
| 2 |
Linde
LIN
|
+$886M |
| 3 |
Amgen
AMGN
|
+$812M |
| 4 |
Pinduoduo
PDD
|
+$400M |
| 5 |
Advanced Micro Devices
AMD
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$475M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Amazon
AMZN
|
+$221M |
| 4 |
VMW
VMware, Inc
VMW
|
+$197M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Rogers Corp
ROG
$2.29B
| $3.28M | ﹤0.01% |
20,040
+520
| +3% | +$75K |
|
1352
Brink's
BCO
$4.55B
| $3.26M | ﹤0.01% |
48,753
-778
| -2% | -$49.4K |
|
1353
Blackstone Mortgage Trust
BXMT
$2.39B
| $3.26M | ﹤0.01% |
182,432
-1,222
| -0.7% | -$26.1K |
|
|
NARI
1354
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $3.25M | ﹤0.01% |
52,618
+4,210
| +9% | +$253K |
|
1355
United Parks & Resorts
PRKS
$2.07B
| $3.24M | ﹤0.01% |
52,901
-4,861
| -8% | -$297K |
|
1356
APi Group
APG
$18.3B
| $3.23M | ﹤0.01% |
215,489
+11,270
| +6% | +$162K |
|
1357
McGrath RentCorp
MGRC
$2.94B
| $3.22M | ﹤0.01% |
+34,508
| New | +$3.41M |
|
1358
Unifirst Corp
UNF
$5.24B
| $3.21M | ﹤0.01% |
18,239
+924
| +5% | +$180K |
|
1359
Boston Beer
SAM
$1.86B
| $3.21M | ﹤0.01% |
9,755
+1,144
| +13% | +$393K |
|
1360
Quaker Houghton
KWR
$2.96B
| $3.2M | ﹤0.01% |
16,179
+800
| +5% | +$153K |
|
1361
Cathay General Bancorp
CATY
$4.23B
| $3.2M | ﹤0.01% |
92,651
+7,858
| +9% | +$323K |
|
1362
Clearway Energy Class C
CWEN
$6.78B
| $3.2M | ﹤0.01% |
102,083
+4,297
| +4% | +$138K |
|
1363
Hamilton Lane
HLNE
$5.53B
| $3.18M | ﹤0.01% |
42,928
+4,336
| +11% | +$320K |
|
|
ENLC
1364
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $3.15M | ﹤0.01% |
290,797
-153
| -0.1% | -$1.81K |
|
1365
ArcBest
ARCB
$3.07B
| $3.15M | ﹤0.01% |
34,062
+2,775
| +9% | +$249K |
|
1366
Certara
CERT
$1.23B
| $3.15M | ﹤0.01% |
130,542
-8,478
| -6% | -$167K |
|
1367
CONMED
CNMD
$1.48B
| $3.14M | ﹤0.01% |
30,249
-578
| -2% | -$55.9K |
|
1368
PagerDuty
PD
$916M
| $3.14M | ﹤0.01% |
89,789
+1,294
| +1% | +$38K |
|
1369
Evolent Health
EVH
$444M
| $3.14M | ﹤0.01% |
96,675
+10,927
| +13% | +$346K |
|
1370
ACI Worldwide
ACIW
$5.34B
| $3.13M | ﹤0.01% |
+116,120
| New | +$3.07M |
|
1371
Ingevity
NGVT
$2.65B
| $3.13M | ﹤0.01% |
43,708
+2,035
| +5% | +$162K |
|
1372
Schneider National
SNDR
$6.18B
| $3.12M | ﹤0.01% |
116,586
+3,814
| +3% | +$103K |
|
1373
Transmedics
TMDX
$3.07B
| $3.12M | ﹤0.01% |
41,169
+1,947
| +5% | +$135K |
|
1374
C3.ai
AI
$1.62B
| $3.12M | ﹤0.01% |
92,826
+5,259
| +6% | +$108K |
|
1375
Blackbaud
BLKB
$2.09B
| $3.11M | ﹤0.01% |
44,875
+2,816
| +7% | +$169K |
|
Similar funds
UBS AM's Q1 2023 Portfolio in Review
As of Q1 2023, UBS AM held 2,762 positions worth $206B, up 8.3% from $191B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q1 2023 filing shows 231 new, 1,328 increased, 856 reduced and 85 closed positions. Its largest new stake was Amgen: 3,308,425 shares worth $800M. The largest sale was Ametek, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2023 buy was Amgen: 3,308,425 shares worth $800M.
- UBS AM added most to Abbott in Q1 2023, an estimated $950M increase.
- UBS AM's biggest Q1 2023 reduction was Ametek, cutting an estimated $475M.
- UBS AM fully exited SVB Financial Group in Q1 2023, selling an estimated $77.3M.
- UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q1 2023.
- UBS AM opened 231 new positions and closed 85 in Q1 2023.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $206B.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.